Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines

作者: Egle Strainiene , Mindaugas Binkis , Silvija Urnikyte , Vaidotas Stankevicius , Ausra Sasnauskiene

DOI: 10.1186/S12885-018-4145-8

关键词:

摘要: Since the first evidence suggesting existence of stem-like cancer cells, process cells reprogramming to stem cell state remains as an attractive tool for stemness research. Current knowledge in field stemness, indicates that microenvironment is a fundamental regulator behavior. With regard this, we investigated changes genome wide gene expression reprogrammed human colon normal epithelial CRL-1831 and carcinoma DLD1 lines grown under more physiologically relevant three-dimensional (3D) culture compared 2D monolayer. Whole were evaluated both cultured 3D conditions over monolayer by microarray analysis. To evaluate biological significance changes, performed pathway enrichment analysis using Kyoto Encyclopedia Genes Genomes (KEGG) database. Gene network was used study relationships between differentially expressed genes (DEGs) functional categories GeneMANIA Cytoscape toolkit. In total, identified 3228 2654 lines, respectively. Furthermore, 1097 commonly regulated lines. KEGG revealed total 129 101 pathways iPSC-CRL-1831 CSC-DLD1, respectively, enriched. Next, grouped these into three categories: transformation/metastasis, interaction, stemness. β-catenin (CTNNB1) confirmed hub all categories. Our present findings suggest common epithelium (iPSC-CRL-1831) adenocarcinoma (CSC-DLD1) microenvironment. addition, demonstrated important transformation tumor metastatic activity are altered during transfer from conditions. Thus, indicate potential models enriched identification new therapeutic targets treatment.

参考文章(38)
Susumu Miyazaki, Hirofumi Yamamoto, Norikatsu Miyoshi, Xin Wu, Hisataka Ogawa, Mamoru Uemura, Junichi Nishimura, Taishi Hata, Ichiro Takemasa, Tsunekazu Mizushima, Masamitsu Konno, Yuichiro Doki, Masaki Mori, Hideshi Ishii, A Cancer Reprogramming Method Using MicroRNAs as a Novel Therapeutic Approach against Colon Cancer: Research for Reprogramming of Cancer Cells by MicroRNAs. Annals of Surgical Oncology. ,vol. 22, pp. 1394- 1401 ,(2015) , 10.1245/S10434-014-4217-1
L Vermeulen, M R Sprick, K Kemper, G Stassi, J P Medema, Cancer stem cells – old concepts, new insights Cell Death & Differentiation. ,vol. 15, pp. 947- 958 ,(2008) , 10.1038/CDD.2008.20
Go J. Yoshida, Hideyuki Saya, Therapeutic strategies targeting cancer stem cells. Cancer Science. ,vol. 107, pp. 5- 11 ,(2016) , 10.1111/CAS.12817
Jean J. Kim, Applications of iPSCs in Cancer Research Biomarker Insights. ,vol. 10, pp. 125- 131 ,(2015) , 10.4137/BMI.S20065
Chujie Bai, Min Yang, Zhengfu Fan, Shu Li, Tian Gao, Zhiwei Fang, Associations of chemo- and radio-resistant phenotypes with the gap junction, adhesion and extracellular matrix in a three-dimensional culture model of soft sarcoma. Journal of Experimental & Clinical Cancer Research. ,vol. 34, pp. 58- 58 ,(2015) , 10.1186/S13046-015-0175-0
Marjorie Pick, Daniel Ronen, Ofra Yanuka, Nissim Benvenisty, Reprogramming of the MHC-I and its regulation by NFκB in human-induced pluripotent stem cells. Stem Cells. ,vol. 30, pp. 2700- 2708 ,(2012) , 10.1002/STEM.1242
Xiao Lu, Tongbiao Zhao, Clinical Therapy Using iPSCs: Hopes and Challenges Genomics, Proteomics & Bioinformatics. ,vol. 11, pp. 294- 298 ,(2013) , 10.1016/J.GPB.2013.09.002
Yanhua Peng, Lihong Chen, Changgong Li, Wenge Lu, Jiandong Chen, Inhibition of MDM2 by hsp90 Contributes to Mutant p53 Stabilization Journal of Biological Chemistry. ,vol. 276, pp. 40583- 40590 ,(2001) , 10.1074/JBC.M102817200
Michael F Clarke, John E Dick, Peter B Dirks, Connie J Eaves, Catriona HM Jamieson, D Leanne Jones, Jane Visvader, Irving L Weissman, Geoffrey M Wahl, None, Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Research. ,vol. 66, pp. 9339- 9344 ,(2006) , 10.1158/0008-5472.CAN-06-3126